UNCYUnicycive Therapeutics Inc. Common Stock

NAS · US · Healthcare · Biotechnology · unicycive.com

5.630USD+0.90%Mkt Cap: 154.22M $P/E: —3d ago

Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a la…

Headline	Source	Time
Older
Unicycive Therapeutics shares rise after second-quarter loss beats forecasts Unicycive Therapeutics, Inc. (NASDAQ:UNCY) shares gained 2.	InvestorsHub	Aug 12
Unicycive Therapeutics (UNCY) Is Down 33.1% After FDA CRL Cites Third-Party Manufacturing Deficiencies	Simply Wall St.	Jul 2
UNCY Stock Clocks Worst Day In A Year — Analysts Keep Buy Ratings Despite ‘5-12 Month Delay’ In Drug Approval	Stocktwits	Jun 30
Sector Update: Healthcare Stocks Softer Late Afternoon	MMT Newswires	Jun 30
Top Midday Decliners	MMT Newswires	Jun 30
UNCY Stock Crashed 45% Today – Why Did FDA Reject Its Kidney Disease NDA For A Second Time?	Stocktwits	Jun 30
Unicycive shares plunge after FDA issues Complete Response Letter for kidney disease drug (UNCY)	InvestorsHub	Jun 30

UNCYUnicycive Therapeutics Inc. Common Stock

Industry Peers